HYPERBARIC OXYGEN THERAPY CLINICAL TRIALS FOR COVID-19

We've long known about the immune boosting capabilities of hyperbaric oxygen therapy but now HBOT is targeting COVID-19 for annihilation. So begins the official clinical trials of it's potential effects for defending against the disease.

HBOT studies for Covid:

https://clinicaltrials.gov/ct2/show/NCT04358926

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232923/